APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pemetrexed Disodium Lyophilized Powder

Compare research editions
View pricing & licenses

Selected research

Industry Research

Pemetrexed Disodium Lyophilized Powder Industry Research Report 2026

Report ID 174023260522 December 2025145 pages

Choose your research edition.

Industry ResearchPemetrexed Disodium Lyophilized Powder Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Pemetrexed Disodium Lyophilized Powder Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Pemetrexed Disodium Lyophilized Powder Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pemetrexed Disodium Lyophilized Powder Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Pemetrexed Disodium Lyophilized Powder Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Pemetrexed Disodium Lyophilized Powder market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Pemetrexed Disodium Lyophilized Powder is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Pemetrexed Disodium Lyophilized Powder is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Pemetrexed Disodium Lyophilized Powder is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Pemetrexed Disodium Lyophilized Powder include Yangtze River Pharmaceutical Group, Jiangsu Simcere Pharmaceutical, Suzhou Thery Pharmaceutical, Suzhou Erye Pharmaceutical, Sichuan Huiyu Pharmaceutical, Shanghai Chemo Wanbang Biopharma, Zhendong Group, Sandoz and Jiangsu Hansoh Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Pemetrexed Disodium Lyophilized Powder market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pemetrexed Disodium Lyophilized Powder Market by Company

Yangtze River Pharmaceutical Group

Jiangsu Simcere Pharmaceutical

Suzhou Thery Pharmaceutical

Suzhou Erye Pharmaceutical

Sichuan Huiyu Pharmaceutical

Shanghai Chemo Wanbang Biopharma

Zhendong Group

Sandoz

Jiangsu Hansoh Pharmaceutical

Nanjing Pharmaceutical Factory

Lianyungang Jaripharm Pharmaceutical

Lilly

Qilu Pharmaceutical

Jiangsu Aosaikang Pharmaceutical

Kelun Pharmaceutical

Hainan Jinrui Pharmaceutical

Fresenius Kabi

Dezhou Deyao Pharmaceutical

Beijing Xiehe Pharmaceutical

Baxter

Zydus Lifesciences

Waverley Pharma

Pfizer (Hospira)

Nang Kuang Pharmaceutical

Eugia Pharma

Dr. Reddy's Laboratories

Biocon

APOTEX

Amneal Pharmaceuticals

Accord Healthcare

Pemetrexed Disodium Lyophilized Powder Segment by Type

100mg/Pcs

500mg/Pcs

Pemetrexed Disodium Lyophilized Powder Segment by Application

Hospitals

Clinics

Others

Pemetrexed Disodium Lyophilized Powder Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pemetrexed Disodium Lyophilized Powder market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pemetrexed Disodium Lyophilized Powder and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pemetrexed Disodium Lyophilized Powder.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Pemetrexed Disodium Lyophilized Powder manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Pemetrexed Disodium Lyophilized Powder by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Pemetrexed Disodium Lyophilized Powder in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pemetrexed Disodium Lyophilized Powder Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Pemetrexed Disodium Lyophilized Powder Sales (k units) of Manufacturers (2021-2026) Table 7. Global Pemetrexed Disodium Lyophilized Powder Sales Market Share by Manufacturers (2021-2026) Table 8. Global Pemetrexed Disodium Lyophilized Powder Revenue of Manufacturers (2021-2026) Table 9. Global Pemetrexed Disodium Lyophilized Powder Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Pemetrexed Disodium Lyophilized Powder Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Pemetrexed Disodium Lyophilized Powder Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Pemetrexed Disodium Lyophilized Powder, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Pemetrexed Disodium Lyophilized Powder, Product Type & Application Table 14. Global Pemetrexed Disodium Lyophilized Powder Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Pemetrexed Disodium Lyophilized Powder by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Yangtze River Pharmaceutical Group Company Information Table 19. Yangtze River Pharmaceutical Group Business Overview Table 20. Yangtze River Pharmaceutical Group Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Yangtze River Pharmaceutical Group Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 22. Yangtze River Pharmaceutical Group Recent Developments Table 23. Jiangsu Simcere Pharmaceutical Company Information Table 24. Jiangsu Simcere Pharmaceutical Business Overview Table 25. Jiangsu Simcere Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Jiangsu Simcere Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 27. Jiangsu Simcere Pharmaceutical Recent Developments Table 28. Suzhou Thery Pharmaceutical Company Information Table 29. Suzhou Thery Pharmaceutical Business Overview Table 30. Suzhou Thery Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Suzhou Thery Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 32. Suzhou Thery Pharmaceutical Recent Developments Table 33. Suzhou Erye Pharmaceutical Company Information Table 34. Suzhou Erye Pharmaceutical Business Overview Table 35. Suzhou Erye Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Suzhou Erye Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 37. Suzhou Erye Pharmaceutical Recent Developments Table 38. Sichuan Huiyu Pharmaceutical Company Information Table 39. Sichuan Huiyu Pharmaceutical Business Overview Table 40. Sichuan Huiyu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Sichuan Huiyu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 42. Sichuan Huiyu Pharmaceutical Recent Developments Table 43. Shanghai Chemo Wanbang Biopharma Company Information Table 44. Shanghai Chemo Wanbang Biopharma Business Overview Table 45. Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 47. Shanghai Chemo Wanbang Biopharma Recent Developments Table 48. Zhendong Group Company Information Table 49. Zhendong Group Business Overview Table 50. Zhendong Group Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Zhendong Group Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 52. Zhendong Group Recent Developments Table 53. Sandoz Company Information Table 54. Sandoz Business Overview Table 55. Sandoz Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Sandoz Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 57. Sandoz Recent Developments Table 58. Jiangsu Hansoh Pharmaceutical Company Information Table 59. Jiangsu Hansoh Pharmaceutical Business Overview Table 60. Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 62. Jiangsu Hansoh Pharmaceutical Recent Developments Table 63. Nanjing Pharmaceutical Factory Company Information Table 64. Nanjing Pharmaceutical Factory Business Overview Table 65. Nanjing Pharmaceutical Factory Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Nanjing Pharmaceutical Factory Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 67. Nanjing Pharmaceutical Factory Recent Developments Table 68. Lianyungang Jaripharm Pharmaceutical Company Information Table 69. Lianyungang Jaripharm Pharmaceutical Business Overview Table 70. Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 72. Lianyungang Jaripharm Pharmaceutical Recent Developments Table 73. Lilly Company Information Table 74. Lilly Business Overview Table 75. Lilly Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Lilly Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 77. Lilly Recent Developments Table 78. Qilu Pharmaceutical Company Information Table 79. Qilu Pharmaceutical Business Overview Table 80. Qilu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Qilu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 82. Qilu Pharmaceutical Recent Developments Table 83. Jiangsu Aosaikang Pharmaceutical Company Information Table 84. Jiangsu Aosaikang Pharmaceutical Business Overview Table 85. Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 87. Jiangsu Aosaikang Pharmaceutical Recent Developments Table 88. Kelun Pharmaceutical Company Information Table 89. Kelun Pharmaceutical Business Overview Table 90. Kelun Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Kelun Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 92. Kelun Pharmaceutical Recent Developments Table 93. Hainan Jinrui Pharmaceutical Company Information Table 94. Hainan Jinrui Pharmaceutical Business Overview Table 95. Hainan Jinrui Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Hainan Jinrui Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 97. Hainan Jinrui Pharmaceutical Recent Developments Table 98. Fresenius Kabi Company Information Table 99. Fresenius Kabi Business Overview Table 100. Fresenius Kabi Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Fresenius Kabi Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 102. Fresenius Kabi Recent Developments Table 103. Dezhou Deyao Pharmaceutical Company Information Table 104. Dezhou Deyao Pharmaceutical Business Overview Table 105. Dezhou Deyao Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Dezhou Deyao Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 107. Dezhou Deyao Pharmaceutical Recent Developments Table 108. Beijing Xiehe Pharmaceutical Company Information Table 109. Beijing Xiehe Pharmaceutical Business Overview Table 110. Beijing Xiehe Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Beijing Xiehe Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 112. Beijing Xiehe Pharmaceutical Recent Developments Table 113. Baxter Company Information Table 114. Baxter Business Overview Table 115. Baxter Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Baxter Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 117. Baxter Recent Developments Table 118. Zydus Lifesciences Company Information Table 119. Zydus Lifesciences Business Overview Table 120. Zydus Lifesciences Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Zydus Lifesciences Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 122. Zydus Lifesciences Recent Developments Table 123. Waverley Pharma Company Information Table 124. Waverley Pharma Business Overview Table 125. Waverley Pharma Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Waverley Pharma Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 127. Waverley Pharma Recent Developments Table 128. Pfizer (Hospira) Company Information Table 129. Pfizer (Hospira) Business Overview Table 130. Pfizer (Hospira) Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Pfizer (Hospira) Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 132. Pfizer (Hospira) Recent Developments Table 133. Nang Kuang Pharmaceutical Company Information Table 134. Nang Kuang Pharmaceutical Business Overview Table 135. Nang Kuang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. Nang Kuang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 137. Nang Kuang Pharmaceutical Recent Developments Table 138. Eugia Pharma Company Information Table 139. Eugia Pharma Business Overview Table 140. Eugia Pharma Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 141. Eugia Pharma Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 142. Eugia Pharma Recent Developments Table 143. Dr. Reddy's Laboratories Company Information Table 144. Dr. Reddy's Laboratories Business Overview Table 145. Dr. Reddy's Laboratories Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 146. Dr. Reddy's Laboratories Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 147. Dr. Reddy's Laboratories Recent Developments Table 148. Biocon Company Information Table 149. Biocon Business Overview Table 150. Biocon Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 151. Biocon Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 152. Biocon Recent Developments Table 153. APOTEX Company Information Table 154. APOTEX Business Overview Table 155. APOTEX Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 156. APOTEX Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 157. APOTEX Recent Developments Table 158. Amneal Pharmaceuticals Company Information Table 159. Amneal Pharmaceuticals Business Overview Table 160. Amneal Pharmaceuticals Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 161. Amneal Pharmaceuticals Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 162. Amneal Pharmaceuticals Recent Developments Table 163. Accord Healthcare Company Information Table 164. Accord Healthcare Business Overview Table 165. Accord Healthcare Pemetrexed Disodium Lyophilized Powder Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 166. Accord Healthcare Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 167. Accord Healthcare Recent Developments Table 168. Global Pemetrexed Disodium Lyophilized Powder Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 169. Global Pemetrexed Disodium Lyophilized Powder Sales by Region (2021-2026) & (k units) Table 170. Global Pemetrexed Disodium Lyophilized Powder Sales Market Share by Region (2021-2026) Table 171. Global Pemetrexed Disodium Lyophilized Powder Sales by Region (2027-2032) & (k units) Table 172. Global Pemetrexed Disodium Lyophilized Powder Sales Market Share by Region (2027-2032) Table 173. Global Pemetrexed Disodium Lyophilized Powder Revenue by Region (2021-2026) & (US$ Million) Table 174. Global Pemetrexed Disodium Lyophilized Powder Revenue Market Share by Region (2021-2026) Table 175. Global Pemetrexed Disodium Lyophilized Powder Revenue by Region (2027-2032) & (US$ Million) Table 176. Global Pemetrexed Disodium Lyophilized Powder Revenue Market Share by Region (2027-2032) Table 177. North America Pemetrexed Disodium Lyophilized Powder Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 178. North America Pemetrexed Disodium Lyophilized Powder Sales by Country (2021-2026) & (k units) Table 179. North America Pemetrexed Disodium Lyophilized Powder Sales by Country (2027-2032) & (k units) Table 180. North America Pemetrexed Disodium Lyophilized Powder Revenue by Country (2021-2026) & (US$ Million) Table 181. North America Pemetrexed Disodium Lyophilized Powder Revenue by Country (2027-2032) & (US$ Million) Table 182. Europe Pemetrexed Disodium Lyophilized Powder Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 183. Europe Pemetrexed Disodium Lyophilized Powder Sales by Country (2021-2026) & (k units) Table 184. Europe Pemetrexed Disodium Lyophilized Powder Sales by Country (2027-2032) & (k units) Table 185. Europe Pemetrexed Disodium Lyophilized Powder Revenue by Country (2021-2026) & (US$ Million) Table 186. Europe Pemetrexed Disodium Lyophilized Powder Revenue by Country (2027-2032) & (US$ Million) Table 187. Asia Pacific Pemetrexed Disodium Lyophilized Powder Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 188. Asia Pacific Pemetrexed Disodium Lyophilized Powder Sales by Country (2021-2026) & (k units) Table 189. Asia Pacific Pemetrexed Disodium Lyophilized Powder Sales by Country (2027-2032) & (k units) Table 190. Asia Pacific Pemetrexed Disodium Lyophilized Powder Revenue by Country (2021-2026) & (US$ Million) Table 191. Asia Pacific Pemetrexed Disodium Lyophilized Powder Revenue by Country (2027-2032) & (US$ Million) Table 192. South America Pemetrexed Disodium Lyophilized Powder Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 193. South America Pemetrexed Disodium Lyophilized Powder Sales by Country (2021-2026) & (k units) Table 194. South America Pemetrexed Disodium Lyophilized Powder Sales by Country (2027-2032) & (k units) Table 195. South America Pemetrexed Disodium Lyophilized Powder Revenue by Country (2021-2026) & (US$ Million) Table 196. South America Pemetrexed Disodium Lyophilized Powder Revenue by Country (2027-2032) & (US$ Million) Table 197. Middle East and Africa Pemetrexed Disodium Lyophilized Powder Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 198. Middle East and Africa Pemetrexed Disodium Lyophilized Powder Sales by Country (2021-2026) & (k units) Table 199. Middle East and Africa Pemetrexed Disodium Lyophilized Powder Sales by Country (2027-2032) & (k units) Table 200. Middle East and Africa Pemetrexed Disodium Lyophilized Powder Revenue by Country (2021-2026) & (US$ Million) Table 201. Middle East and Africa Pemetrexed Disodium Lyophilized Powder Revenue by Country (2027-2032) & (US$ Million) Table 202. Global Pemetrexed Disodium Lyophilized Powder Sales by Type (2021-2026) & (k units) Table 203. Global Pemetrexed Disodium Lyophilized Powder Sales by Type (2027-2032) & (k units) Table 204. Global Pemetrexed Disodium Lyophilized Powder Sales Market Share by Type (2021-2026) Table 205. Global Pemetrexed Disodium Lyophilized Powder Sales Market Share by Type (2027-2032) Table 206. Global Pemetrexed Disodium Lyophilized Powder Revenue by Type (2021-2026) & (US$ Million) Table 207. Global Pemetrexed Disodium Lyophilized Powder Revenue by Type (2027-2032) & (US$ Million) Table 208. Global Pemetrexed Disodium Lyophilized Powder Revenue Market Share by Type (2021-2026) Table 209. Global Pemetrexed Disodium Lyophilized Powder Revenue Market Share by Type (2027-2032) Table 210. Global Pemetrexed Disodium Lyophilized Powder Price by Type (2021-2026) & (US$/unit) Table 211. Global Pemetrexed Disodium Lyophilized Powder Price by Type (2027-2032) & (US$/unit) Table 212. Global Pemetrexed Disodium Lyophilized Powder Sales by Application (2021-2026) & (k units) Table 213. Global Pemetrexed Disodium Lyophilized Powder Sales by Application (2027-2032) & (k units) Table 214. Global Pemetrexed Disodium Lyophilized Powder Sales Market Share by Application (2021-2026) Table 215. Global Pemetrexed Disodium Lyophilized Powder Sales Market Share by Application (2027-2032) Table 216. Global Pemetrexed Disodium Lyophilized Powder Revenue by Application (2021-2026) & (US$ Million) Table 217. Global Pemetrexed Disodium Lyophilized Powder Revenue by Application (2027-2032) & (US$ Million) Table 218. Global Pemetrexed Disodium Lyophilized Powder Revenue Market Share by Application (2021-2026) Table 219. Global Pemetrexed Disodium Lyophilized Powder Revenue Market Share by Application (2027-2032) Table 220. Global Pemetrexed Disodium Lyophilized Powder Price by Application (2021-2026) & (US$/unit) Table 221. Global Pemetrexed Disodium Lyophilized Powder Price by Application (2027-2032) & (US$/unit) Table 222. Key Raw Materials Table 223. Raw Materials Key Suppliers Table 224. Pemetrexed Disodium Lyophilized Powder Distributors List Table 225. Pemetrexed Disodium Lyophilized Powder Customers List Table 226. Pemetrexed Disodium Lyophilized Powder Industry Trends Table 227. Pemetrexed Disodium Lyophilized Powder Industry Drivers Table 228. Pemetrexed Disodium Lyophilized Powder Industry Restraints Table 229. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pemetrexed Disodium Lyophilized Powder Product Image Figure 5. Global Pemetrexed Disodium Lyophilized Powder Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Pemetrexed Disodium Lyophilized Powder Market Size (2021-2032) & (US$ Million) Figure 7. Global Pemetrexed Disodium Lyophilized Powder Sales (2021-2032) & (k units) Figure 8. Global Pemetrexed Disodium Lyophilized Powder Average Price (US$/unit) & (2021-2032) Figure 9. 100mg/Pcs Product Image Figure 10. 500mg/Pcs Product Image Figure 11. Hospitals Product Image Figure 12. Clinics Product Image Figure 13. Others Product Image Figure 14. Global Pemetrexed Disodium Lyophilized Powder Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Pemetrexed Disodium Lyophilized Powder, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Pemetrexed Disodium Lyophilized Powder Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Pemetrexed Disodium Lyophilized Powder Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Pemetrexed Disodium Lyophilized Powder Sales by Region in 2025 Figure 20. Global Pemetrexed Disodium Lyophilized Powder Revenue by Region in 2025 Figure 21. North America Pemetrexed Disodium Lyophilized Powder Market Size by Country in 2025 Figure 22. North America Pemetrexed Disodium Lyophilized Powder Sales Market Share by Country (2021-2032) Figure 23. North America Pemetrexed Disodium Lyophilized Powder Revenue Market Share by Country (2021-2032) Figure 24. United States Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Pemetrexed Disodium Lyophilized Powder Market Size by Country in 2025 Figure 28. Europe Pemetrexed Disodium Lyophilized Powder Sales Market Share by Country (2021-2032) Figure 29. Europe Pemetrexed Disodium Lyophilized Powder Revenue Market Share by Country (2021-2032) Figure 30. Germany Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Pemetrexed Disodium Lyophilized Powder Market Size by Country in 2025 Figure 41. Asia Pacific Pemetrexed Disodium Lyophilized Powder Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Pemetrexed Disodium Lyophilized Powder Revenue Market Share by Country (2021-2032) Figure 43. China Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Pemetrexed Disodium Lyophilized Powder Market Size by Country in 2025 Figure 52. South America Pemetrexed Disodium Lyophilized Powder Sales Market Share by Country (2021-2032) Figure 53. South America Pemetrexed Disodium Lyophilized Powder Revenue Market Share by Country (2021-2032) Figure 54. Brazil Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Pemetrexed Disodium Lyophilized Powder Market Size by Country in 2025 Figure 58. Middle East and Africa Pemetrexed Disodium Lyophilized Powder Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Pemetrexed Disodium Lyophilized Powder Revenue Market Share by Country (2021-2032) Figure 60. Egypt Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Pemetrexed Disodium Lyophilized Powder Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Pemetrexed Disodium Lyophilized Powder Sales Market Share by Type (2021-2032) Figure 66. Global Pemetrexed Disodium Lyophilized Powder Revenue Market Share by Type (2021-2032) Figure 67. Global Pemetrexed Disodium Lyophilized Powder Price (US$/unit) by Type (2021-2032) Figure 68. Global Pemetrexed Disodium Lyophilized Powder Sales Market Share by Application (2021-2032) Figure 69. Global Pemetrexed Disodium Lyophilized Powder Revenue Market Share by Application (2021-2032) Figure 70. Global Pemetrexed Disodium Lyophilized Powder Price (US$/unit) by Application (2021-2032) Figure 71. Pemetrexed Disodium Lyophilized Powder Value Chain Figure 72. Pemetrexed Disodium Lyophilized Powder Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Pemetrexed Disodium Lyophilized Powder Industry Opportunities and Challenges

Scope & coverage.

Types
  • 100mg/Pcs
  • 500mg/Pcs
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Yangtze River Pharmaceutical Group
  • Jiangsu Simcere Pharmaceutical
  • Suzhou Thery Pharmaceutical
  • Suzhou Erye Pharmaceutical
  • Sichuan Huiyu Pharmaceutical
  • Shanghai Chemo Wanbang Biopharma
  • Zhendong Group
  • Sandoz
  • Jiangsu Hansoh Pharmaceutical
  • Nanjing Pharmaceutical Factory
  • Lianyungang Jaripharm Pharmaceutical
  • Lilly
  • Qilu Pharmaceutical
  • Jiangsu Aosaikang Pharmaceutical
  • Kelun Pharmaceutical
  • Hainan Jinrui Pharmaceutical
  • Fresenius Kabi
  • Dezhou Deyao Pharmaceutical
  • Beijing Xiehe Pharmaceutical
  • Baxter
  • Zydus Lifesciences
  • Waverley Pharma
  • Pfizer (Hospira)
  • Nang Kuang Pharmaceutical
  • Eugia Pharma
  • Dr. Reddy's Laboratories
  • Biocon
  • APOTEX
  • Amneal Pharmaceuticals
  • Accord Healthcare

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Pemetrexed Disodium Lyophilized Powder Market Size (2021-2032)
  4. 2.2.2 Global Pemetrexed Disodium Lyophilized Powder Sales (2021-2032)
  5. 2.2.3 Global Pemetrexed Disodium Lyophilized Powder Market Average Price (2021-2032)
  6. 2.3 Pemetrexed Disodium Lyophilized Powder by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 100mg/Pcs
  9. 2.3.3 500mg/Pcs
  10. 2.4 Pemetrexed Disodium Lyophilized Powder by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospitals
  13. 2.4.3 Clinics
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Pemetrexed Disodium Lyophilized Powder Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Pemetrexed Disodium Lyophilized Powder Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Pemetrexed Disodium Lyophilized Powder Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Pemetrexed Disodium Lyophilized Powder Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Pemetrexed Disodium Lyophilized Powder Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Pemetrexed Disodium Lyophilized Powder, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Pemetrexed Disodium Lyophilized Powder, Product Type & Application
  8. 3.8 Global Manufacturers of Pemetrexed Disodium Lyophilized Powder, Established Date
  9. 3.9 Global Pemetrexed Disodium Lyophilized Powder Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Yangtze River Pharmaceutical Group
  2. 4.1.1 Yangtze River Pharmaceutical Group Company Information
  3. 4.1.2 Yangtze River Pharmaceutical Group Business Overview
  4. 4.1.3 Yangtze River Pharmaceutical Group Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Yangtze River Pharmaceutical Group Pemetrexed Disodium Lyophilized Powder Product Portfolio
  6. 4.1.5 Yangtze River Pharmaceutical Group Recent Developments
  7. 4.2 Jiangsu Simcere Pharmaceutical
  8. 4.2.1 Jiangsu Simcere Pharmaceutical Company Information
  9. 4.2.2 Jiangsu Simcere Pharmaceutical Business Overview
  10. 4.2.3 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  12. 4.2.5 Jiangsu Simcere Pharmaceutical Recent Developments
  13. 4.3 Suzhou Thery Pharmaceutical
  14. 4.3.1 Suzhou Thery Pharmaceutical Company Information
  15. 4.3.2 Suzhou Thery Pharmaceutical Business Overview
  16. 4.3.3 Suzhou Thery Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Suzhou Thery Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  18. 4.3.5 Suzhou Thery Pharmaceutical Recent Developments
  19. 4.4 Suzhou Erye Pharmaceutical
  20. 4.4.1 Suzhou Erye Pharmaceutical Company Information
  21. 4.4.2 Suzhou Erye Pharmaceutical Business Overview
  22. 4.4.3 Suzhou Erye Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Suzhou Erye Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  24. 4.4.5 Suzhou Erye Pharmaceutical Recent Developments
  25. 4.5 Sichuan Huiyu Pharmaceutical
  26. 4.5.1 Sichuan Huiyu Pharmaceutical Company Information
  27. 4.5.2 Sichuan Huiyu Pharmaceutical Business Overview
  28. 4.5.3 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  30. 4.5.5 Sichuan Huiyu Pharmaceutical Recent Developments
  31. 4.6 Shanghai Chemo Wanbang Biopharma
  32. 4.6.1 Shanghai Chemo Wanbang Biopharma Company Information
  33. 4.6.2 Shanghai Chemo Wanbang Biopharma Business Overview
  34. 4.6.3 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium Lyophilized Powder Product Portfolio
  36. 4.6.5 Shanghai Chemo Wanbang Biopharma Recent Developments
  37. 4.7 Zhendong Group
  38. 4.7.1 Zhendong Group Company Information
  39. 4.7.2 Zhendong Group Business Overview
  40. 4.7.3 Zhendong Group Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Zhendong Group Pemetrexed Disodium Lyophilized Powder Product Portfolio
  42. 4.7.5 Zhendong Group Recent Developments
  43. 4.8 Sandoz
  44. 4.8.1 Sandoz Company Information
  45. 4.8.2 Sandoz Business Overview
  46. 4.8.3 Sandoz Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Sandoz Pemetrexed Disodium Lyophilized Powder Product Portfolio
  48. 4.8.5 Sandoz Recent Developments
  49. 4.9 Jiangsu Hansoh Pharmaceutical
  50. 4.9.1 Jiangsu Hansoh Pharmaceutical Company Information
  51. 4.9.2 Jiangsu Hansoh Pharmaceutical Business Overview
  52. 4.9.3 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  54. 4.9.5 Jiangsu Hansoh Pharmaceutical Recent Developments
  55. 4.10 Nanjing Pharmaceutical Factory
  56. 4.10.1 Nanjing Pharmaceutical Factory Company Information
  57. 4.10.2 Nanjing Pharmaceutical Factory Business Overview
  58. 4.10.3 Nanjing Pharmaceutical Factory Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Nanjing Pharmaceutical Factory Pemetrexed Disodium Lyophilized Powder Product Portfolio
  60. 4.10.5 Nanjing Pharmaceutical Factory Recent Developments
  61. 4.11 Lianyungang Jaripharm Pharmaceutical
  62. 4.11.1 Lianyungang Jaripharm Pharmaceutical Company Information
  63. 4.11.2 Lianyungang Jaripharm Pharmaceutical Business Overview
  64. 4.11.3 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  66. 4.11.5 Lianyungang Jaripharm Pharmaceutical Recent Developments
  67. 4.12 Lilly
  68. 4.12.1 Lilly Company Information
  69. 4.12.2 Lilly Business Overview
  70. 4.12.3 Lilly Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Lilly Pemetrexed Disodium Lyophilized Powder Product Portfolio
  72. 4.12.5 Lilly Recent Developments
  73. 4.13 Qilu Pharmaceutical
  74. 4.13.1 Qilu Pharmaceutical Company Information
  75. 4.13.2 Qilu Pharmaceutical Business Overview
  76. 4.13.3 Qilu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Qilu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  78. 4.13.5 Qilu Pharmaceutical Recent Developments
  79. 4.14 Jiangsu Aosaikang Pharmaceutical
  80. 4.14.1 Jiangsu Aosaikang Pharmaceutical Company Information
  81. 4.14.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  82. 4.14.3 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  84. 4.14.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  85. 4.15 Kelun Pharmaceutical
  86. 4.15.1 Kelun Pharmaceutical Company Information
  87. 4.15.2 Kelun Pharmaceutical Business Overview
  88. 4.15.3 Kelun Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Kelun Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  90. 4.15.5 Kelun Pharmaceutical Recent Developments
  91. 4.16 Hainan Jinrui Pharmaceutical
  92. 4.16.1 Hainan Jinrui Pharmaceutical Company Information
  93. 4.16.2 Hainan Jinrui Pharmaceutical Business Overview
  94. 4.16.3 Hainan Jinrui Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Hainan Jinrui Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  96. 4.16.5 Hainan Jinrui Pharmaceutical Recent Developments
  97. 4.17 Fresenius Kabi
  98. 4.17.1 Fresenius Kabi Company Information
  99. 4.17.2 Fresenius Kabi Business Overview
  100. 4.17.3 Fresenius Kabi Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Fresenius Kabi Pemetrexed Disodium Lyophilized Powder Product Portfolio
  102. 4.17.5 Fresenius Kabi Recent Developments
  103. 4.18 Dezhou Deyao Pharmaceutical
  104. 4.18.1 Dezhou Deyao Pharmaceutical Company Information
  105. 4.18.2 Dezhou Deyao Pharmaceutical Business Overview
  106. 4.18.3 Dezhou Deyao Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Dezhou Deyao Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  108. 4.18.5 Dezhou Deyao Pharmaceutical Recent Developments
  109. 4.19 Beijing Xiehe Pharmaceutical
  110. 4.19.1 Beijing Xiehe Pharmaceutical Company Information
  111. 4.19.2 Beijing Xiehe Pharmaceutical Business Overview
  112. 4.19.3 Beijing Xiehe Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Beijing Xiehe Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  114. 4.19.5 Beijing Xiehe Pharmaceutical Recent Developments
  115. 4.20 Baxter
  116. 4.20.1 Baxter Company Information
  117. 4.20.2 Baxter Business Overview
  118. 4.20.3 Baxter Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Baxter Pemetrexed Disodium Lyophilized Powder Product Portfolio
  120. 4.20.5 Baxter Recent Developments
  121. 4.21 Zydus Lifesciences
  122. 4.21.1 Zydus Lifesciences Company Information
  123. 4.21.2 Zydus Lifesciences Business Overview
  124. 4.21.3 Zydus Lifesciences Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Zydus Lifesciences Pemetrexed Disodium Lyophilized Powder Product Portfolio
  126. 4.21.5 Zydus Lifesciences Recent Developments
  127. 4.22 Waverley Pharma
  128. 4.22.1 Waverley Pharma Company Information
  129. 4.22.2 Waverley Pharma Business Overview
  130. 4.22.3 Waverley Pharma Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Waverley Pharma Pemetrexed Disodium Lyophilized Powder Product Portfolio
  132. 4.22.5 Waverley Pharma Recent Developments
  133. 4.23 Pfizer (Hospira)
  134. 4.23.1 Pfizer (Hospira) Company Information
  135. 4.23.2 Pfizer (Hospira) Business Overview
  136. 4.23.3 Pfizer (Hospira) Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Pfizer (Hospira) Pemetrexed Disodium Lyophilized Powder Product Portfolio
  138. 4.23.5 Pfizer (Hospira) Recent Developments
  139. 4.24 Nang Kuang Pharmaceutical
  140. 4.24.1 Nang Kuang Pharmaceutical Company Information
  141. 4.24.2 Nang Kuang Pharmaceutical Business Overview
  142. 4.24.3 Nang Kuang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 Nang Kuang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  144. 4.24.5 Nang Kuang Pharmaceutical Recent Developments
  145. 4.25 Eugia Pharma
  146. 4.25.1 Eugia Pharma Company Information
  147. 4.25.2 Eugia Pharma Business Overview
  148. 4.25.3 Eugia Pharma Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  149. 4.25.4 Eugia Pharma Pemetrexed Disodium Lyophilized Powder Product Portfolio
  150. 4.25.5 Eugia Pharma Recent Developments
  151. 4.26 Dr. Reddy's Laboratories
  152. 4.26.1 Dr. Reddy's Laboratories Company Information
  153. 4.26.2 Dr. Reddy's Laboratories Business Overview
  154. 4.26.3 Dr. Reddy's Laboratories Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  155. 4.26.4 Dr. Reddy's Laboratories Pemetrexed Disodium Lyophilized Powder Product Portfolio
  156. 4.26.5 Dr. Reddy's Laboratories Recent Developments
  157. 4.27 Biocon
  158. 4.27.1 Biocon Company Information
  159. 4.27.2 Biocon Business Overview
  160. 4.27.3 Biocon Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  161. 4.27.4 Biocon Pemetrexed Disodium Lyophilized Powder Product Portfolio
  162. 4.27.5 Biocon Recent Developments
  163. 4.28 APOTEX
  164. 4.28.1 APOTEX Company Information
  165. 4.28.2 APOTEX Business Overview
  166. 4.28.3 APOTEX Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  167. 4.28.4 APOTEX Pemetrexed Disodium Lyophilized Powder Product Portfolio
  168. 4.28.5 APOTEX Recent Developments
  169. 4.29 Amneal Pharmaceuticals
  170. 4.29.1 Amneal Pharmaceuticals Company Information
  171. 4.29.2 Amneal Pharmaceuticals Business Overview
  172. 4.29.3 Amneal Pharmaceuticals Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  173. 4.29.4 Amneal Pharmaceuticals Pemetrexed Disodium Lyophilized Powder Product Portfolio
  174. 4.29.5 Amneal Pharmaceuticals Recent Developments
  175. 4.30 Accord Healthcare
  176. 4.30.1 Accord Healthcare Company Information
  177. 4.30.2 Accord Healthcare Business Overview
  178. 4.30.3 Accord Healthcare Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
  179. 4.30.4 Accord Healthcare Pemetrexed Disodium Lyophilized Powder Product Portfolio
  180. 4.30.5 Accord Healthcare Recent Developments
5 Global Pemetrexed Disodium Lyophilized Powder Market Scenario by Region
  1. 5.1 Global Pemetrexed Disodium Lyophilized Powder Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Pemetrexed Disodium Lyophilized Powder Sales by Region: 2021-2032
  3. 5.2.1 Global Pemetrexed Disodium Lyophilized Powder Sales by Region: 2021-2026
  4. 5.2.2 Global Pemetrexed Disodium Lyophilized Powder Sales by Region: 2027-2032
  5. 5.3 Global Pemetrexed Disodium Lyophilized Powder Revenue by Region: 2021-2032
  6. 5.3.1 Global Pemetrexed Disodium Lyophilized Powder Revenue by Region: 2021-2026
  7. 5.3.2 Global Pemetrexed Disodium Lyophilized Powder Revenue by Region: 2027-2032
  8. 5.4 North America Pemetrexed Disodium Lyophilized Powder Market Facts & Figures by Country
  9. 5.4.1 North America Pemetrexed Disodium Lyophilized Powder Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Pemetrexed Disodium Lyophilized Powder Sales by Country (2021-2032)
  11. 5.4.3 North America Pemetrexed Disodium Lyophilized Powder Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Pemetrexed Disodium Lyophilized Powder Market Facts & Figures by Country
  16. 5.5.1 Europe Pemetrexed Disodium Lyophilized Powder Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Pemetrexed Disodium Lyophilized Powder Sales by Country (2021-2032)
  18. 5.5.3 Europe Pemetrexed Disodium Lyophilized Powder Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Pemetrexed Disodium Lyophilized Powder Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Pemetrexed Disodium Lyophilized Powder Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Pemetrexed Disodium Lyophilized Powder Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Pemetrexed Disodium Lyophilized Powder Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Pemetrexed Disodium Lyophilized Powder Market Facts & Figures by Country
  41. 5.7.1 South America Pemetrexed Disodium Lyophilized Powder Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Pemetrexed Disodium Lyophilized Powder Sales by Country (2021-2032)
  43. 5.7.3 South America Pemetrexed Disodium Lyophilized Powder Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Pemetrexed Disodium Lyophilized Powder Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Pemetrexed Disodium Lyophilized Powder Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Pemetrexed Disodium Lyophilized Powder Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Pemetrexed Disodium Lyophilized Powder Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Pemetrexed Disodium Lyophilized Powder Sales by Type (2021-2032)
  2. 6.1.1 Global Pemetrexed Disodium Lyophilized Powder Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Pemetrexed Disodium Lyophilized Powder Sales Market Share by Type (2021-2032)
  4. 6.2 Global Pemetrexed Disodium Lyophilized Powder Revenue by Type (2021-2032)
  5. 6.2.1 Global Pemetrexed Disodium Lyophilized Powder Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Pemetrexed Disodium Lyophilized Powder Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Pemetrexed Disodium Lyophilized Powder Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Pemetrexed Disodium Lyophilized Powder Sales by Application (2021-2032)
  2. 7.1.1 Global Pemetrexed Disodium Lyophilized Powder Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Pemetrexed Disodium Lyophilized Powder Sales Market Share by Application (2021-2032)
  4. 7.2 Global Pemetrexed Disodium Lyophilized Powder Revenue by Application (2021-2032)
  5. 7.2.1 Global Pemetrexed Disodium Lyophilized Powder Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Pemetrexed Disodium Lyophilized Powder Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Pemetrexed Disodium Lyophilized Powder Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Pemetrexed Disodium Lyophilized Powder Value Chain Analysis
  2. 8.1.1 Pemetrexed Disodium Lyophilized Powder Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Pemetrexed Disodium Lyophilized Powder Production Mode & Process
  5. 8.2 Pemetrexed Disodium Lyophilized Powder Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Pemetrexed Disodium Lyophilized Powder Distributors
  8. 8.2.3 Pemetrexed Disodium Lyophilized Powder Customers
9 Global Pemetrexed Disodium Lyophilized Powder Analyzing Market Dynamics
  1. 9.1 Pemetrexed Disodium Lyophilized Powder Industry Trends
  2. 9.2 Pemetrexed Disodium Lyophilized Powder Industry Drivers
  3. 9.3 Pemetrexed Disodium Lyophilized Powder Industry Opportunities and Challenges
  4. 9.4 Pemetrexed Disodium Lyophilized Powder Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst